Komo Plant Based Foods Grows Distribution Across Quebec, Ontario, and Maritimes Life Science Investing
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate Life Science Investing
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders Pharmaceutical Investing
Knight to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference Pharmaceutical Investing
CLASS ACTION UPDATE for AI, AUPH and LILM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
LAWSUITS FILED AGAINST AFRM, AKBA and ABBV - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
TOP RANKED ROSEN LAW FIRM Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, IBM and IRNT Pharmaceutical Investing
AUPH SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Veklury® is First and Only Approved Treatment for Pediatric Patients Under 12 Years of Age with COVID-19 Pharmaceutical Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
